Navigation Links
Breast Overlay

ProductsBreast Overlay
Company Shielding International Inc.
Item Breast Overlay
Features 
  • Closures: 2" Belt w/Quick Release Buckle
    • Description Shielding's new Breast Overlay Apron is exclusively designed to provide extra coverage for this vulnerable area. The adjustable velcro flaps allow for a quick, comfortable fit, plust added coverage for both underarm and front of the delicate breast tissue.
    Info Shielding International Inc.
    Customer Service: (800) 292-2247
    Web site: http://www.shieldingintl.com

    Related medicine products :

    1. Breast Cancer Camera
    2. Breast Biopsy Guard
    3. Multi Frequency Linear Breast Transducer UST-5539-7.5
    4. Multi Frequency Linear Breast HST Transducer UST-5542
    5. Multi Frequency Linear Breast HST Transducer UST-5543
    6. Multi Frequency Linear Breast Transducer
    7. Smooth Round Moderate Plus Profile Breast Implant
    8. Smooth Round Moderate Profile Breast Implant
    9. Elite™ Gels Round Moderate Breast Implant
    10. Elite™ Gels Round High Profile Breast Implant
    11. Universal Breast Augmentation Support
    ...our practice with a practice management system. D...tronically or on paper. Your patient statements ca...mbined traditional software and billing services i...ny computer from anywhere - multiples offices or h...
    ...s lens incorporate 3 mirrors angled at 76°, 66...chamber as well as central and peripheral fundus v... are accurately angled and spaced 120° apart t...central portion of the lens also provides direct o...
    ...featuring ultra-clear Volk 3-Mirror optics, incorp...deg; and 60°. The 3 Mirror is ideal for anter...viewing and treatment. The retinal viewing mirrors...sualized fundus. The central portion of the lens a...
    The AFX Lens is a direct image lens designed for use in an air-filled eye. In addition to its use as a primary air-fluid exchange vitrectomy lens, the low profile and sutureless design make it well s
    Medicine Products:
    (Date:7/18/2008)... ITHACA, N.Y. Behavior spanning the wide spectrum... the 12th International Behavioral Ecology Congres...ral Ecology, on Aug. 10 -14, 2008, at Cornell Univ...r sessions, the congress will feature plenary sess...ecology and evolutionary biology, Yale University,...
    (Date:7/18/2008)... Giving children preventive antibiotics within on...reduces the risk for serious infections after the ...ished in the August issue of Pediatric Infectious...print). Children who received antibiotics outside ...times more likely to develop serious infections at...
    (Date:7/18/2008)... VISTA, Calif., July 18 /PRNewswire/ -- Actress...ished herself as a tireless crusader in the search...egimens to help manage the,disease., McCarthy inc...p,specialty probiotic product, ThreeLac(TM), into ...her experience in her book Louder than,Words: A Mo...
    (Date:7/18/2008)...Finding could help advance individualized medicine...ly 18 (HealthDay News) -- Scientists may have foun...y help determine whether or not they respond to th...cally, researchers at the Mayo Clinic have found t...ould help select which patients should try this dr...
    Breaking Medicine News(10 mins):Health News:Averting postsurgical infections in kids: Give antibiotics within hour before first incision 2Health News:Global Health Trax Joins Fight Against Autism With Jenny McCarthy and Generation Rescue 2Health News:Gene Variations May Predict Antidepressant Response 2
    ..., have been cured at New Delhis Indraprastha Apoll...s, aged up to 18 years, were suffering from congen...year old child underwent an Intra Cardiac Echo (IC...tal, and was just among a handful in the country q...
    ...nd that two compounds from lobster shells, chitin ...erties. The researchers said that the compounds co...t healing and antiseptic properties, as well as to... and germination in seeds. Chitin is a very commo...
    ...odule received clearance from the U.S. Food and Dr...d its BBL(TM) broadband pulsed light received cle...resents the latest technological advancement from ...er energy to target fatty tissue. Using the ProLip...
    ... million soldiers, with the military to implement ... health scandals, state media reported on Friday. ...food products and eliminating the common practice ...same plate, according to an announcement by the Pe...
    Other Medicine News:Health News:Lobster Shells Have Great Healing and Antiseptic Properties 2Health News:Sciton Receives FDA Clearance for Lipolysis and Wrinkle Treatment 2
    (Date:7/16/2008)...ank discomfort as #1 reason to avoid discussing ED...disease, INDIANAPOLIS, July 16 /PRNewswire-FirstC... of men with erectile dysfunction (ED) surveyed,re...ons, such as heart,disease and diabetes, nearly 40...heir doctors. The survey, conducted by Ipsos Publi...
    (Date:7/15/2008)...y 15 /- Abeome Corporation, a,Georgia...c equity,investment by Cato BioVentures and a coll...ract research and development organization. The in...nued development of Abeome,s lead,ovarian cancer p...mproves the development of,monoclonal antibodies a...
    (Date:7/15/2008)...July 15 /- Alfacell Corpora...entered into a distribution,agreement with Megapha...l,for the commercialization of ONCONASE(R) (ranpi...g candidate, recently completed an international,c...able malignant,mesothelioma (UMM)., Under the agr...
    (Date:7/14/2008)...ly 14 /- SyntheMed, Inc. (O...ngaged in the development,and commercialization of...urgical implants, announced today that REPEL-CV(R)...m for the reduction of adhesions,following cardiac...use in,pediatric patients who undergo open heart s...
    Breaking Medicine Technology:The ED Conversation Dilemma: Forty Percent of Men with ED Don't Talk to Their Doctor, Survey Finds 2The ED Conversation Dilemma: Forty Percent of Men with ED Don't Talk to Their Doctor, Survey Finds 3The ED Conversation Dilemma: Forty Percent of Men with ED Don't Talk to Their Doctor, Survey Finds 4The ED Conversation Dilemma: Forty Percent of Men with ED Don't Talk to Their Doctor, Survey Finds 5Abeome and Cato Research to Collaborate on Ovarian Cancer Therapeutic 2Alfacell Announces ONCONASE(R) Distribution and Marketing Agreement with Megapharm for Israel 2Alfacell Announces ONCONASE(R) Distribution and Marketing Agreement with Megapharm for Israel 3Alfacell Announces ONCONASE(R) Distribution and Marketing Agreement with Megapharm for Israel 4SyntheMed Receives Canadian Approval for REPEL-CV(R) 2Mayo Clinic study finds that after heart attack most patients stop taking life saving drugs 5519 1Mayo Clinic study finds that after heart attack most patients stop taking life saving drugs 5519 2New Computerized Scans Effective for Spotting Clogged Arteries 5516 1New Computerized Scans Effective for Spotting Clogged Arteries 5516 2New Computerized Scans Effective for Spotting Clogged Arteries 5516 3New Data Examines the Effect of Adding a Statin to Optimized Treatment for Patients with Advanced Heart Failure 753 1New Data Examines the Effect of Adding a Statin to Optimized Treatment for Patients with Advanced Heart Failure 753 2New Data Examines the Effect of Adding a Statin to Optimized Treatment for Patients with Advanced Heart Failure 753 3New Data Examines the Effect of Adding a Statin to Optimized Treatment for Patients with Advanced Heart Failure 753 4New Data Examines the Effect of Adding a Statin to Optimized Treatment for Patients with Advanced Heart Failure 753 5Imaging Diagnostic Systems CTLM Technology Presented at Congress of World Society for Breast Health 748 1Imaging Diagnostic Systems CTLM Technology Presented at Congress of World Society for Breast Health 748 2Imaging Diagnostic Systems CTLM Technology Presented at Congress of World Society for Breast Health 748 3
    ...IANGLE PARK, N.C., Mar 8, 2007 (CCNMatthews via CO...SX:AHX)(AMEX:ADH), a,biopharmaceutical company wit...elopment, today announced that Dr. Antonella,Perot...O,Foundation, an investigator in Adherex,s Europea...esent data today from that study at,the 5th Intern...
    ... FLORENCE, Italy - 8 March 2007 - Cancer drug,deve... announces,positive initial findings from its seco...mall cell lung cancer. , This 30-patient trial tes...th carboplatin and paclitaxel chemotherapy.,Invest... 43% of,patients showed disease stabilisation, whi...
    Other Medicine Technology:Data From Adherex's European Phase Ib/II Trial of ADH-1 to be,Presented at International Symposium on Targeted Anticancer,Therapies 2Data From Adherex's European Phase Ib/II Trial of ADH-1 to be,Presented at International Symposium on Targeted Anticancer,Therapies 3Antisoma plc (UK) - Second lung cancer trial adds to positive data,on AS1404 2Antisoma plc (UK) - Second lung cancer trial adds to positive data,on AS1404 3